NASDAQ:MGX | Profit Breakdown | Metagenomi Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$28.77M-$27.48M-$27.48M
2026-03-31$1.25M-$24.59M-$23.05M-$23.06M
2025-12-31$3.91M-$24.37M-$22.49M-$22.53M
2025-09-30$8.66M-$22.84M-$20.63M-$20.39M
2025-06-30$8.51M-$20.99M-$19.86M-$19.91M
2025-03-31$4.13M-$27.82M-$24.94M-$25.04M
2024-12-31$9.61M-$20.62M-$24.61M-$23.4M
2024-09-30$11.51M-$22.38M-$20.88M-$18.77M
2024-06-30$20.01M-$16.86M-$12.94M-$10.74M
2024-03-31$11.16M-$29.03M-$25.15M-$25.15M
2023-12-31$12.4M-$20.2M-$16.57M-$19.29M
2023-09-30$12.36M-$22.4M-$18.61M-$19.82M
2023-06-30$11.34M-$17.96M-$11.11M-$13.01M
2023-03-31$8.66M-$17.94M-$13.94M-$16.13M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$25.21M-$96.01M-$87.93M-$87.87M
2024-12-31$52.3M-$88.9M-$83.57M-$78.06M
2023-12-31$44.76M-$78.49M-$60.23M-$68.26M